Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Platinum-Resistant Fallopian Tube Carcinoma × HhAntag691 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 3 Skin Neoplasms 2 Neoplasms 2 Platinum-Resistant Fallopian Tube Carcinoma 1 Neoplasms, Basal Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Basal Cell Nevus Syndrome 1

Interventions

atezolizumab 1 HhAntag691 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05538091 2025-11-26

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

University of Pittsburgh

Phase 2 Recruiting

Platinum-Resistant Fallopian Tube Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡